6533b834fe1ef96bd129e0fe
RESEARCH PRODUCT
Glycemic Variability Assessment with a 14-Day Continuous Glucose Monitoring System: When and How Long to Measure MAGE (Mean Amplitude of Glucose Excursion) for Optimal Reliability?
Benjamin BouilletJean-michel PetitA. RoulandEmilienne QuilotBruno VergèsElise PignolS. Baillot-rudoniAbdelmadjid Djeffalsubject
Blood Glucosemedicine.medical_specialtyEndocrinology Diabetes and MetabolismBiomedical Engineering030209 endocrinology & metabolismBioengineering030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineTechnology ReportsInternal MedicinemedicineHumansReliability (statistics)GlycemicType 1 diabetesContinuous glucose monitoringbusiness.industryBlood Glucose Self-MonitoringReproducibility of ResultsGold standard (test)Glucose excursionmedicine.diseaseGlucoseAmplitudeDiabetes Mellitus Type 2Cardiologybusinessdescription
Mean amplitude of glucose excursion (MAGE) is considered as the “gold standard” for assessing the short-term within-day glycemic variability (GV), which is an important component of overall glycemic control. A 14-day continuous glucose monitoring system is now widely used and allows easier assessment of GV. However, it is still unknown whether MAGE, usually calculated on a 48-hour period is identical whatever the time during the 14-day lifespan of the sensor and whether a longer time period might give additional information. We evaluated in 68 patients with type 1 diabetes, MAGE during three 2-day periods (day1-day3; day6-day8; day11-day13) and during periods of 3 days and 4 days. MAGE calculated at the three 2-day periods were identical and not different from MAGE of the 3-day or 4-day periods.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-02-12 | Journal of Diabetes Science and Technology |